Alnylam Pharmaceuticals Inc R&D Day 2020 (Event 1) Transcript
Good morning, and welcome to day 1 of our Virtual Alnylam R&D Day Event. I'm Christine Lindenboom, Senior Vice President of Investor Relations and Corporate Communications at Alnylam.
With me today are John Maraganore, Chief Executive Officer, who'll provide some opening remarks and general context; Yvonne Greenstreet, President and Chief Operating Officer, who'll share an overview of our commercial progress; Akshay Vaishnaw, President of R&D, will discuss our approach to sustainable innovation before we take 2 deep dives, the first being on our Alnylam TTR franchise. In that session, we are pleased to have Dr. Philip Hawkins of the National Amyloidosis Center, Royal Free Hospital and University College London, join us alongside John Vest, Vice President of Clinical Research at Alnylam.
Additionally, we are excited to have Dr. Akshay Desai, Director, Cardiomyopathy and Heart Failure Program, Cardiovascular Division of Brigham and Women's Hospital, an Associate Professor of
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
